Treatment
For MS now viable
Tyruko, a biosimilar
Providing a cost-effective
Alternative

#fda #ms #tyruko #biosimilar #tysabri #cinquain #poetry

http://www.medicalnewstoday.com/articles/fda-approves-first-natalizumab-biosimilar-for-ms-treatment

Trying to escape pharmacy before I have to parrot this script. Safe n effective ~

#pharmacy #ontario #biosimilar #canada #healthcare #ethics

Happy #PharmPhriday! A question I get a lot is “what’s a #biosimilar?” Well, it’s like a #generic but for #biologics

Because a biologic is made from something living, you can’t exactly copy the drug recipe like you can with generics. There are also some differences in testing.

A biosimilar has no clinically meaningful differences from an existing FDA-approved biologic.

A generic drug demonstrates bioequivalence to an existing FDA-approved drug.

Infographic from https://www.fda.gov/media/166334/download

📔 @epiphare publie un article dans la revue BioDrugs

🔎 Severe Hypersensitivity Reactions at #Biosimilar versus Originator #Rituximab Treatment Initiation, Switch and Over Time #EpiVerse

💡 Cette étude ne permet pas de conclure à une association entre exposition aux biosimilaires du Rituximab et hospitalisation pour choc anaphylactique ou réaction sérique à la suite de l’injection, aussi bien à l’initiation, au switch, et au cours du temps.

👉 https://www.epi-phare.fr/rapports-detudes-et-publications/rituximab-hypersensibilite/

GSK and Novartis report earnings — Amgen adopts a two-price strategy for first Humira biosimilar, Amjevita — Legislative hurdles anticipated for biopharma in 2023 -- See more on our front page news http://bit.ly/w28kSd #gsk #novartis #earnings #amgen #humira #abbvie #biosimilar #drugpricing #legislation #biopharma #biotech #biotechnology #pharma #pharmanews #cafepharma

RT @MondayNightIBD
#IBDPoll1️⃣
🆓#CME👉🏼 http://bit.ly/3ioJwmM

39 y/o #IBD in clinical & endo remission on adalimumab 40 mg SQ Q2 wks.
Receives a letter from her insurance that she needs to #switch to ADAL #biosimilar and she contacts your office.
How do you proceed?
(RP=reference product)

RT @MondayNightIBD
#IBDPoll2️⃣

🆓#CME👉🏼 http://bit.ly/3ioJwmM

Which #adalimumab #biosimilar has #interchangeability status?

💎To learn more what all the new Biosimilar mean to your #IBD patients & practice join our Q/A w @GI_PharmD @DCharabaty 👇🏽👇🏽

RT @MondayNightIBD
#IBDPoll1️⃣
🆓#CME👉🏼 http://bit.ly/3ioJwmM

39 y/o #IBD in clinical & endo remission on adalimumab 40 mg SQ Q2 wks.
Receives a letter from her insurance that she needs to #switch to ADAL #biosimilar and she contacts your office.
How do you proceed?
(RP=reference product)

RT @MondayNightIBD
#IBDPoll2️⃣

🆓#CME👉🏼 http://bit.ly/3ioJwmM

Which #adalimumab #biosimilar has #interchangeability status?

💎To learn more what all the new Biosimilar mean to your #IBD patients & practice join our Q/A w @GI_PharmD @DCharabaty 👇🏽👇🏽

RT @DCharabaty
@MondayNightIBD @GI_PharmD Q1. There’s a 🌊 of #adalimumab (ADA) Biosimilars coming to the US Market in 2023

@GI_PharmD let’s start w the basics ! What is a #Biosimilar ?

RT @GI_PharmD
@DCharabaty @MondayNightIBD A3a. An #interchangeable #biosimilar may be substituted for RF and dispensed by the pharmacist -
without requiring a new prescription for interchangeable product from prescriber (per state laws 🧑‍⚖️).

RT @DCharabaty
@GI_PharmD @MondayNightIBD Q4. More than ever we are going to need the help of ⭐️ #PharmD ⭐️ to navigate the #Biosimilar space !

What is the difference between low & high concentration of ADA? Is this something we have to think of with the different Biosimilars @GI_PharmD ?

RT @MondayNightIBD
#IBDPoll1️⃣
🆓#CME👉🏼 http://bit.ly/3ioJwmM

39 y/o #IBD in clinical & endo remission on adalimumab 40 mg SQ Q2 wks.
Receives a letter from her insurance that she needs to #switch to ADAL #biosimilar and she contacts your office.
How do you proceed?
(RP=reference product)

RT @MondayNightIBD
#IBDPoll2️⃣

🆓#CME👉🏼 http://bit.ly/3ioJwmM

Which #adalimumab #biosimilar has #interchangeability status?

💎To learn more what all the new Biosimilar mean to your #IBD patients & practice join our Q/A w @GI_PharmD @DCharabaty 👇🏽👇🏽

#IBDPoll2️⃣

🆓#CME👉🏼 http://bit.ly/3ioJwmM

Which #adalimumab #biosimilar has #interchangeability status?

💎To learn more what all the new Biosimilar mean to your #IBD patients & practice join our Q/A w @GI_PharmD @DCharabaty 👇🏽👇🏽

#IBDPoll1️⃣
🆓#CME👉🏼 http://bit.ly/3ioJwmM

39 y/o #IBD in clinical & endo remission on adalimumab 40 mg SQ Q2 wks.
Receives a letter from her insurance that she needs to #switch to ADAL #biosimilar and she contacts your office.
How do you proceed?
(RP=reference product)

@NeuroDrugDoc

oh thank you 🥰. it's not looking like it's designed for mobile so will try on desktop.

thank you for jump starting me on trying to understand #biologic v. #biosimilar

reading this now to learn more.
https://www.medicalnewstoday.com/articles/biologics-and-biosimilars#summary

Initiative in Congress aims to improve access to biosimilars

https://www.fiercepharma.com/pharma/proposal-congress-would-eliminate-interchangeable-status-biosimilars #biosimilar #pharma

Initiative in Congress aims to improve access to biosimilars

https://www.fiercepharma.com/pharma/proposal-congress-would-eliminate-interchangeable-status-biosimilars #biosimilar #pharma

RT @BioconBiologics@twitter.com

Biocon Biologics’ biosimilar Insulin Glargine is the 1st interchangeable #biosimilar #insulin approved by #USFDA, a testament to our internal scientific capabilities, excellence & robust quality comparability data. #WorldDiabetesDay #GlobalBiosimilarsWeek https://www.youtube.com/watch?v=xFkGjrk874Y

🐦🔗: https://twitter.com/BioconBiologics/status/1591979168274993152